Lauren Miller, PA-C, kicked off the inaugural 2023 Inflammatory Disease Summit by discussing the psychosocial impacts related to atopic dermatitis, psoriasis, and hidradenitis suppurativa.
Kaitlyn Bader
Advertisement
Articles by Kaitlyn Bader
FDA action is no longer expected in Q3 of 2023.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on AJMC
1
Cytokines Linked With Drug Resistance in Ovarian Cancer, but Underlying Mechanisms Remain Unclear
2
CHEST 2025 Highlights: Future of Respiratory Vaccines and the Impact of Federal Funding Cuts
3
Elinzanetant Shows Consistent Efficacy, Safety, and Sleep Benefits Across Studies
4
Mepolizumab Reduces Health Care Resource Utilization, Work Impairment in Severe Asthma
5
